CHARACTERISTICS OF HEPATITIS B VIRUS INFECTIONS IN NEWBORNS WHOM MOTHERS ARE POSITIVE FOR HBsAg AT 103 MILITARY HOSPITAL

Lê Thị Hồng Vân1, Lê Thị Vân Trang1, Ngô Tuấn Minh1, Nguyễn Việt Dũng1, Nguyễn Xuân Khái1,
1 Military Hospital 103

Main Article Content

Abstract

Objectives: evaluate the status of hepatitis B virus infection in newborns of mothers with HBsAg (+) and the relationship between the appearance of HBV markers in cord blood with the presence of these markers in maternal blood. Subjects and methods: A cross‐sectional study. 120 newborns of mothers with HBsAg (+) were at the Obstetrics Department, 103 Military Hospital, from August 2021 to December 2021. Results: Among 120 newborns with HsAg (+), the percentage of HBV markers in cord blood of the children was: the rate of HBsAg (+) 60.8%, HBeAg (+) 13.3% and HBV DNA ( +) was 16.7%. In maternal blood, the rate of HBeAg (+) was 30.8%, HBV DNA ≥5 log 10 copies/mL was 25.0%, mean ALT and AST levels were 25.7 ± 11.3 and 29.3 ± 12.7 U/L respectively. The rate of HBsAg (+) in the group of mothers with HBeAg (+) was 91.9%, higher than the group of HBeAg (-) was 47.0%, the difference was statistically significant, p<0.01. In the group of mothers with HBV DNA levels ≥5 log 10 copies/mL, 80.0% of children had HBsAg (+), 54.4% higher than the group with HBV DNA <5 log 10 copies/mL. The difference was statistically significant, p<0.01. Conclusions: the rate of HBsAg (+) in cord blood of the newborns was 60.8%, the rate of HBeAg (+) was 13.3% and the rate of HBV DNA (+) was 16.7%. In maternal blood, HBeAg (+) and HBV DNA levels ≥ 5 log 10 copies/mL are factors that increase the risk of mother-to-child transmission of HBV.

Article Details

References

1. World Health Organization (2020), "Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy: web annex A: systematic review of the efficacy and safety of antiviral therapy during pregnancy", pp.
2. KT Yip, SM Chan,TL Que (2006), "Immuno-prophylaxis of babies borne to hepatitis B carrier mothers". Hong Kong Med J, 12(5), pp. 368-74.
3. Yi-Yang Zhu, Ying-Zi Mao, Wei-Ling Wu. et al. (2010), "Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure?". Clinical vaccine immunology, 17(12), pp. 1836-1841.
4. Tianyan Chen, Jing Wang, Yuling Feng. et al. (2013), "Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg (+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?". BMC infectious diseases, 13(1), pp. 1-8.
5. Lê Đình Vĩnh Phúc,Huỳnh Hồng Quang (2016), "Nghiên cứu tỉ lệ và đặc điểm của nhiễm virus viêm gan B ở phụ nữ độ tuổi sinh đẻ từ 20 đến 35 tại trung tâm y khoa Medic thành phố Hồ Chí Minh năm 2015". Tạp chí Y học dự phòng, 8(181), pp. 108-117.
6. Phí Đức Long (2014). Đánh giá đáp ứng tạo kháng thể đối với vắcxin phòng viêm gan B ở trẻ có mẹ mang HBsAg. Luận án Tiến sỹ Y học, Đại học Y Hà Nội.
7. Kai‐Chi Chang, Mei‐Hwei Chang, Chien‐Nan Lee. et al. (2019), "Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers". Alimentary pharmacology therapeutics, 50(3), pp. 306-316.
8. Chu Thị Thu Hà,Đinh Phương Hòa (2008), "Hiệu quả của biện pháp phối hợp can thiệp tiêm phòng Globulin miễn dịch và vắcxin viêm gan B cho trẻ trong vòng 24 giờ đầu sau khi sinh tại Hà Nội". Tạp chí Y học dự phòng, 4(96), pp. 24-27.
9. IS Elefsiniotis, M Papadakis, G Vlahos. et al. (2009), "Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers". Intervirology, 52(3), pp. 132-134.